Clinical Trials
14 trialsNCT05557474 2026-02-17
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
Chung Shan Medical University
Recruiting
NCT05891197 2025-07-01
START
Lyell Immunopharma, Inc.
Terminated
NCT05701787 2025-05-22
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
Shanghai Chest Hospital
Recruiting
NCT05324436 2025-01-20
A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
Bristol-Myers Squibb
Completed
NCT05189054 2023-12-27
Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors
Peking University Third Hospital
Recruiting
NCT04636775 2023-12-11
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
University of Kansas Medical Center
Unknown
NCT04976296 2022-03-17
MRD Monitoring in Lung Cancer After Resection
Guangdong Provincial People's Hospital
Recruiting
NCT04634630 2021-06-01
The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung
Azienda Ospedaliero-Universitaria di Modena
Completed
NCT04813068 2021-05-28
Lung Cancer Patients' Attitudes to a Second Course of Radiotherapy
NHS Greater Glasgow and Clyde
Unknown
NCT03791034 2021-05-11
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Samsung Medical Center
Recruiting
NCT04768491 2021-02-24
Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC
Peking Union Medical College
Unknown
NCT04492969 2020-07-31
Prospective Observation of Failure Patterns in NSCLC Treated With ICIs
Fudan University
Unknown
NCT01040312 2019-05-23
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Daiichi Sankyo
Completed
NCT01271959 2012-10-05
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Precision Therapeutics
Terminated